Pharmaceutical
Indications

 

38 Results were found on Technologies

Leading Researchers:

IAPP Oligomers as a Target for Type 2 Diabetes Novel Immunotherapy

TechnologyStabilized human IAPP (hIAPP) oligomers were used for the development of active immunization of type 2 diabetes. This promising novel approach for the treatment of type 2 diabetes is doable due to the establishment of a new protocol for... Read More >

Leading Researchers:

Mouse model of progressive multiple sclerosis

The Technology Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by damage to the neuronal myelin sheath, which results in different levels of muscle paralysis that can lead to neuronal death. In... Read More >

Leading Researchers:

Quantitative confluency measurement of culture growth

The invention is an image processing method of light microscopy images for the purpose of quantifying density of cells in cultures . A grayscale image of a cell culture is digitally captured using a light microscope and a CCD camera... Read More >

Leading Researchers:

Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Biomarker for Fibrosis relating to the diagnosis of fibrotic diseases based on total PCPE in serum

Collaboration with Dr Shlomit Mesilaty, Dr Yair Anikster, Prof Ido Wolf Metabolic Enzymatic Laboratory, Sheba Medical Center. Bone metastasis is a major clinical concern that can cause severe pain, bone fractures, spinal cord... Read More >

Leading Researchers:

METHODS AND KITS FOR DETERMINING PREDISPOSITION TO DEVELOP KIDNEY DISEASES

Many rare kidney disorders exhibit a monogenic, Mendelian pattern of inheritance. Population-based genetic studies have identified many genetic variants associated with an increased risk of developing common kidney diseases. Strongly associated... Read More >

Leading Researchers:

Silver-enzyme hybrids for the treatment bacterial and fungal biofilms in chronic wounds, burns and surgical wounds

TechnologyThe silver-enzyme hybrid cream is a formulation consisting of soluble, single glucose oxidase molecules coated with thin (~1.5nm) metallic silver coating. This formulation will penetrate into mixed microbial biofilms and affect... Read More >

Leading Researchers:

Immunotherapy for Stroke and Cognition in a Cerebral Amyloid Angiopathy Animal Model

Cerebrovascular dysfunction is a fundamental part of the pathology of several neurodegenerative diseases and rated as one of the most prominent cause for dementia. Cerebral amyloid angiopathy (CAA) results in intra-parenchymal and subarachnoid... Read More >

Optimization of Myocardial Tissue Repair and Regeneration with Iron-oxide Nanoparticles Formulated in Macrophage-Targeted Carriers

The Technology A novel approach for the treatment of AMI has been developed using IONPs. IONPs, when injected into the infarcted myocardium, lead to improved heart function after MI. IONPs activate anti-inflammatory macrophages and... Read More >

Leading Researchers:

EG30 for the treatment of Alzheimer's disease

EG-30: clinical phase drug for AMD and Glaucoma EG-30 – the highlights: · Excellent safety profile in healthy volunteers and glaucoma... Read More >

Leading Researchers:

Hemostatic Soft Tissue Adhesives

Novel bio-adhesives based on the natural polymers, gelatin (protein) and alginate (polysaccharide), and a carbodiimide crosslinking agent. The carbodiimide crosslinking agent is much less toxic than other crosslinking agents used in bioadhesives... Read More >